Skip to content
Governance Register
US nonprofit · EIN 841558631 · Chicago, ILiSource and licenceOrganisation record IRS Exempt Organizations Business Master File (EIN 841558631) - NTEE activity code, address.Board and officers IRS Form 990 annual filings, Part VII (directors, trustees, officers, key employees), read year by year to observe time served.Latest return IRS Form 990 series e-file data - 990 for the year to 30 June 2025: assets, liabilities, staff, website, telephone, pay, grants paid (Schedule I).Finances by year IRS Form 990 e-file data - total revenue and total expenses by tax year.Renewal outlook Computed by Governance Register from the observed filing history and filed revenue. Not a statement that the organisation is recruiting.Deductibility IRS Publication 78 data (code PC), downloaded 18 October 2026.State registers Colorado Secretary of State (17 October 2026).Licence US Federal Government public domain.How we handle data

Pulmonary Fibrosis Foundation's network

16 people2 organisationsi16 people and 2 organisations on this map.The large node is the subject of this page. Solid lines are what the register itself records (16). Violet dotted lines (2) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.

The board

16 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Time served and departures are observed across annual filings. Observed time served is a lower bound - a member may have joined before the first year on record. The organisation reported 15 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.
NameRole as filedSinceOn the board
Wayne Pan MD PHD MBA ChairChair2023
3 yrs
David McNinchDirector2018
8 yrs
Devi Kumar-Nambiar JD MBADirector2023
3 yrs
Grant BallantyneDirector2025
1 yr
Harold R Collard MDDirector2025
1 yr
Heather KagelDirector2022
4 yrs
Jeff HarrisDirector2018
8 yrs
Julie HalstonDirector2021
5 yrs
Kenneth Fang MDDirector - Term2023
3 yrs
Laurie Chandler CFPTreasurer2018
8 yrs
Martin AttwellCompany secretary2021
5 yrs
Patricia RosaVice Chair2021
5 yrs
PJ KamaniDirector2021
5 yrs
Susan Jacobs RN MsDirector2023
3 yrs
Terence HalesDirector2018
8 yrs
William T Schmidt (also filed as Bill Schmidt, William Schmidt, William Schmidt)Director2018
8 yrs
Under 5 years5 to 6 years6 years or moreShow all 16 →

Officers and senior leadership

19 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.
NameTitle as filedOn the filings
Amy WardzalaVP, Development2025
Heather KundertSR Dr, Corp Rel thru 06/4/20182018
Janet BianchettaVP, Financesince 2022
Jennifer MeffordVP, Corporate Partnershipssince 2023
Jessica ShoreVP, Research & Programssince 2022
Junelle SpellerVP, PFF Registrysince 2022
Jeri WebbAssociate VP, Conf & Meetingssince 2018
Katherine BeinVP, Advocacy and Programssince 2024
Kate GatesVP, Advocacy & Programs2022
Kathryn TrebonskyVP, Finance Thru 04/01/212021
Kerrie TrebonskyVP, Financesince 2018
Laura SadlerChief Program & Bus Dev Offcrsince 2018
Mary KienerSenior Director, HR & Admin2024
Pauline BianchiVP, Research & Programssince 2019
Rex EdwardsVP, PFF Patient Registrysince 2018
Scott StaszakPresident & CEOsince 2018
Seth KleinVP, Developmentsince 2019
William T SchmidtDirector/President and CEOsince 2020
Zoe BubanyVP, Board & External Relationssince 2018

Pay and hours

year to 30 June 2025iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.
NameTitle as filedHours a weekPay from the organisationRelated organisationsOther
Scott StaszakPresident & CEO40$422k$11k
Franck RahaghiFormer President & CEO40$284k$6k
Seth KleinChief Development Officer40$209k$7k
Jessica ShoreSr. VP, Clinical Affairs and Quality40$202k$7k
Janet BianchettaChief Financial Officer40$184k$23k
Jennifer MeffordVP, Corporate Partnerships40$173k$6k
Katherine BeinVP, Advocacy and Programs40$159k$32k
Zoe BubanyVP, Board and External Relations40$142k$22k
Amy WardzalaVP, Development40$132k$27k
Wayne Pan MD PhD MBAChair1$0
Patricia RosaVice Chair1$0
Martin AttwellSecretary1$0
Laurie Chandler CFPTreasurer1$0
Grant BallantyneDirector1$0
Harold R Collard MDDirector1$0
Terence HalesDirector1$0
Julie HalstonDirector1$0
Jeff HarrisDirector1$0
Susan Jacobs RN MsDirector1$0
Heather KagelDirector1$0
Pj KamaniDirector1$0
Devi Kumar-Nambiar JD MBADirector1$0
David McNinchDirector1$0
William SchmidtDirector1$0
Kenneth Fang MDDirector - Term1$0

Colorado roster

26 listediOfficers, directors and trustees from the latest filing with the Colorado Secretary of State (document 20263015708). Titles are as filed; some entries are registered agents or custodians of records rather than board members. Source: data.colorado.gov, public domain.
NameTitle as filed
Harold CollardDirector
Laurie ChandlerTreasurer
Jennifer MeffordVP, Corporate Partnerships
Seth KleinCDO
Susan JacobsDirector
Patricia RosaVice Chair
Pj KamaniDirector
Martin AttwellSecretary
Wayne PanChair
Julie HalstonDirector
Scott Staszak
Jeff HarrisDirector
Scott StaszakPresident and CEO
Devi Kumar-NambiarDirector
Heather KagelDirector
Terence HalesDirector
Kenneth FangDirector
William SchmidtDirector
Zoe BubanyVP, Board and External Relations
Franck RahaghiFormer President & CEO
Katherine BeinVP, Advocacy and Programs
Jessica ShoreSr. VP, Clinical Affairs and Quality
David McNinchDirector
Janet BianchettaCFO
Grant BallantyneDirector
Amy WardzalaVP, Development

About

Legal name
Pulmonary Fibrosis Foundation
EIN
841558631
Address
223 W Jackson Blvd Ste 350, Chicago, IL, 60606-6974
State
Illinois
Mission
The pulmonary fibrosis foundation is committed to accelerating research, empowering our community, and transforming care so that everyone with pulmonary fibrosis can live a better life. Our ultimate goal is to find a cure for pulmonary fibrosis. (as filed on the Form 990)
Activity (NTEE)
G45 Voluntary health associations and medical disciplines
IRS classification
501(c)03 (tax-exempt under section 501(c)(3) where shown)
Classified purpose
Voluntary Health Associations & Medical Disciplines
Size band
8 (IRS master file code)
Formed
2000
Principal officer
Scott Staszak (as named on the Form 990)
IRS ruling date
1 November 2000
Status
Code 01 (unconditional exemption)
Form 990 filings on record
8, latest 2025
IRS Publication 78
PC (contributions deductible)

Most connected

Longest observed on the filings

≥8years on the filingsDavid McNinch
≥8years on the filingsJeff Harris
≥8years on the filingsLaurie Chandler CFP
≥8years on the filingsTerence Hales

Latest return

year to 30 June 2025iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 30 June 2025. US dollars, as filed.
Total assets
$17.5m
Total liabilities
$3.8m
Net assets or fund balances
$13.7m
Contributions and grants received
$8m
Program service revenue
$1.6m
Grants and similar paid out
$620k
Employees
39
Volunteers
4,833

Filed finances

1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.
Tax yearTotal revenueTotal expensesSurplus or deficit
2023$8.3m$9mDeficit $733k

As filed on the IRS Form 990. US dollars.

Grants paid

6 listediFrom Schedule I of the Form 990: grants and assistance to organisations in the United States, largest first (up to 25). Schedule I is filed only by organisations that gave more than $5,000 to any one recipient.
RecipientPurposeAmount
Weill Medical College of Cornell UniversityAssociations of ct-assessed airway diameter and clinical outcomes in pulmonary fibrosis$100k
Johns Hopkins University School of MedicinePulmonary hypertension prediction in patients with interstitial lung disease$100k
Cedars-Sinai Medical CenterRegulation of her2 activation in fibroblast invasion and pulmonary fibrosis.$100k
University of Kansas Medical Center Research InstituteMetabolomics of preclinical pulmonary fibrosis$100k
Vanderbilt University Medical CenterHif2 modulation of alveolar repair in pulmonary fibrosis$100k
The Rector & Visitors of the University of VirginiaThe role of b-1 cells and igm in pulmonary fibrosis pathogensis$100k